Poseida Therapeutics Has Debt But No Earnings Should You Worry?
Slightly above 67% of Poseida Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Poseida Therapeutics suggests that many traders are alarmed regarding Poseida Therapeutics' prospects. Poseida Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Poseida Therapeutics' earnings reports, geopolitical events, and overall market trends.
Poseida |
David Iben put it well when he said, Volatility is not a risk we care about. What we care about is avoiding the...
Read at simplywall.st
![]() |
Poseida Therapeutics Fundamental Analysis
We analyze Poseida Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Poseida Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Poseida Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Poseida Therapeutics is currently under evaluation in target price category among its peers.
Poseida Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Poseida Therapeutics stock to make a market-neutral strategy. Peer analysis of Poseida Therapeutics could also be used in its relative valuation, which is a method of valuing Poseida Therapeutics by comparing valuation metrics with similar companies.
Peers
Poseida Therapeutics Related Equities
PASG | Passage Bio | 11.11 | ||||
PEPG | PepGen | 7.69 | ||||
IPSC | Century Therapeutics | 6.12 | ||||
PHVS | Pharvaris | 4.09 | ||||
CYTK | Cytokinetics | 3.89 | ||||
ANTX | AN2 Therapeutics | 3.36 | ||||
STOK | Stoke Therapeutics | 1.35 | ||||
DYN | Dyne Therapeutics | 0.77 | ||||
PLRX | Pliant Therapeutics | 0.73 | ||||
RVMD | Revolution Medicines | 0.25 | ||||
MLYS | Mineralys Therapeutics, | 0.07 | ||||
MOLN | Molecular Partners | 0.26 | ||||
RVPH | Reviva Pharmaceuticals | 2.38 | ||||
GBIO | Generation Bio | 2.56 | ||||
CUE | Cue Biopharma | 4.00 | ||||
INAB | In8bio | 13.33 | ||||
LTRN | Lantern Pharma | 13.99 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Poseida Stock
If you are still planning to invest in Poseida Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Poseida Therapeutics' history and understand the potential risks before investing.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |